Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAF versus TDF in early- and mid-pregnancy for chronic hepatitis B
ChiCTR2500098753Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir alafenamide and tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB) (2 arms), sponsored by The Third Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Incidence of ALT above normal (>=1 time). Planned start Mar 2025; status: not yet recruiting.
02
Drugs
tenofovir alafenamidetenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2500098753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098753.